Current Studies and Clinical Trials

The UnionDerm research team is currently engaged in multiple cutting-edge trials and studies. If you are interested in participating in one of our studies, please scroll down to the “Participating in Future Studies” section at the bottom of this page to learn more.

We are currently recruiting for:

1. A treatment for hair loss in Skin of Color patients using the Folix laser system

  • We are recruiting male and female patients between 21 – 55 years of age with Fitzpatrick skin types 5 & 6 who are seeking treatment for hair loss and hair thinning. Since this treatment has been FDA-approved to safely and effectively improve hair loss in skin types 1 – 4, this study’s purpose is to confirm these results in subjects with darker skin types (5 – 6) who have not used other hair growth treatments in the past 90 days. After confirming qualification at the screening visit, participants will receive 4 treatments, spaced 4 weeks apart, and will return for follow-up visits 1 month and 3 months post their last treatment to assess the results (total: 7 visits). You will be compensated $75 for visit and $100 for each follow-up visit, for a total of $575 upon study completion.

2. Aviclear laser treatment for mild-to-severe acne on the face and back

  • We are looking for participants with mild-to-severe acne on the face and/ or back to receive 3 monthly treatments with the Aviclear® laser. As the laser has already been shown to be safe and effective for treating mild to severe inflammatory acne vulgaris, the purpose of this study is to evaluate the clinical performance of the large handpiece and assess user experience. To participate, you must be at least 18 years old with mild-to-severe acne on the face and/ or back. If you are interested in participating or would like more information, please contact our research team to see if you may qualify.

3. Investigational oral drug for female pattern hair loss

  • This clinical trial is studying a new investigational oral tablet aimed at restoring hair, without the development of hormonal or heart-related side effects. If you’re a woman aged 18-65 experiencing pattern hair loss, you may qualify. There is no cost to you to participate, and insurance is not required. Learn more about the benefits of joining this hair loss clinical trial and see if you may qualify today.

4. Laser Treatment for Sebaceous Hyperplasia

  • We are currently recruiting participants between the ages of 18 and 80 for a clinical research study investigating the AviClear laser device as a treatment for sebaceous hyperplasia. Eligible participants must have a minimum of one and up to ten clinically diagnosed sebaceous hyperplasia lesions. If you are interested in participating or would like to learn more, please contact our research team to see if you may qualify.

Upcoming studies are listed below. Please note that the studies below are not yet open for enrollment. Contact our research team to express your interest and be added to the contact list.

1. Males and females between 18 to 64 years of age who are seeking treatment for the appearance of abdominal fat. Must have a BMI greater than 18.5 and less than 30 kg/m^2, and weight greater than or equal to 50 kg (110.2 lbs) to qualify.

* You may not be eligible to participate if any of the following apply:

  • On weight reduction medication, weight reduction programs, or GLP-1 within the past 6 months
  • Has a diagnosis of coagulation disorders or is receiving anticoagulant/antiplatelet therapy
  • Has active or prior history of malignancies in the past 5 years or is currently being evaluated for a possible malignancy
  • Has ventral abdominal or umbilical hernia or has had repairs
  • Has undergone the following procedures:
      • Previous surgery that caused scar tissue in the treatment area (exceptions: laparoscopic surgery)
      • Abdominoplasty or liposuction to the treatment area
      • Body contouring or fat reduction procedures in the past 12 months
      • Has used medication that is delivered via subcutaneous injection to the treatment area in the past 4 weeks
  • Is undergoing chronic systemic steroid or immunosuppressive therapy
  • Has liver cirrhosis, inadequate liver function, or any renal impairment

PARTICIPATING IN FUTURE STUDIES

Study participants receive study-related exams, lab tests, and the investigational study medication or treatment at no charge. Additionally, participants are typically compensated for their time by the study sponsor.

For more information about participating in clinical trials at UnionDerm, please call us at (212) 366-5400 or email us at research@unionderm.com. Please specify which study you are interested in.

How can we help you?